体外受精显微镜市场 - 按产品类型（胚胎、立体、直立、倒置）、最终用途（临床、学术研究） - 全球预测 2024 年 - 2032 年

In-vitro Fertilization Microscope Market - By Product Type (Embryo, Stereo, Upright, Inverted), End-use (Clinical, Academic Research) - Global Forecast 2024 - 2032

出版日期: 2024年03月13日 | 出版商:

Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在辅助生殖技术 (ART) 进步的推动下，体外受精显微镜市场预计 2024 年至 2032 年复合年增长率将达到 8.5%。随着越来越多的夫妇面临不孕问题并寻求医疗干预来怀孕，对体外受精 (IVF) 显微镜等专业设备的需求正在激增。根据世界卫生组织的数据，全球成年人口中约有 17.5%（即约六分之一的人）面临不孕问题。此外，已开发国家和发展中经济体对生育治疗的认识不断提高，加上可支配收入不断增加，刺激了体外受精程序的采用。

高解析度成像系统的发展以及延时成像和自动胚胎评估等功能提高了 IVF 程序的准确性和效率。这些进步不仅提高了生育治疗的成功率，还简化了 IVF 实验室的工作流程，吸引医疗保健提供者投资最先进的显微镜解决方案。

体外受精显微镜产业根据产品类型、最终用途和地区进行分类。

根据产品，体视显微镜领域的市场价值将在2024 年至2032 年间呈现8.6% 的成长率。精緻的标本过程。此外，这些显微镜的人体工学设计和使用者友善的介面有助于提高 IVF 实验室的工作流程效率。

在创新和对生殖生物学更广泛理解的支持下，学术研究最终用途领域的体外受精显微镜市场预计到 2032 年复合年增长率将达到 8.9%。学术机构协助进行突破性研究，以改善生育治疗和推进辅助生殖技术。随着研究人员探索新的方法和技术来提高胚胎髮育和植入成功率，针对 IVF 研究特定需求客製化的高品质显微镜设备的需求不断增长。

由于不孕问题日益普遍，到 2032 年，亚太地区体外受精显微镜产业将实现 9.1% 的成长率。在医疗保健基础设施方面已经有了重大倡议和投资，特别是在中国、印度和日本等国家。此外，庞大的人口基数和不断提高的医疗保健标准将有助于该地区对体外受精显微镜的需求不断增长。

产业生态系统分析
产业影响力
- 成长动力
  - 由于成功率提高，采用率提高
  - 不断进步的技术进步
  - 政府政策不断升级
- 产业陷阱与挑战
  - 限制 IVF 指南
  - 商品化和工业化
成长潜力分析
监管环境
技术景观
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
竞争定位矩阵
战略展望矩阵

第 5 章：市场估计与预测：按产品类型，2018 年 - 2032 年

主要趋势
胚胎显微镜
体视显微镜
正置显微镜
倒置显微镜

第 6 章：市场估计与预测：依最终用途，2018 - 2032 年

主要趋势
诊所
学术研究
其他最终用户

第 7 章：市场估计与预测：按地区划分，2018 年 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第 8 章：公司简介

Eppendorf AG
Euromex Microscopen BV
Hamilton Thorne Ltd.
Labomed, Inc.
Leica Microsystems A/S (Danaher Corporation)
Linkam Scientific Instruments Limited
Meiji Techno
NARISHIGE Group
Nikon Corporation
Olympus Corporation
Sutter Instrument Company

简介目录

Product Code: 8485

In-vitro fertilization microscope market is estimated to record 8.5% CAGR from 2024 to 2032, driven by advancements in assisted reproductive technologies (ART). As more number of couples face infertility issues and seek medical interventions to conceive, the demand for specialized equipment like In-vitro fertilization (IVF) microscopes is surging. As per WHO, approximately 17.5% of the global adult population, roughly 1 in 6 individuals face infertility issues. Additionally, increasing awareness about fertility treatments coupled with rising disposable incomes in both developed and developing economies has spurred the adoption of IVF procedures.

The development of high-resolution imaging systems, along with features like time-lapse imaging and automated embryo assessment, has enhanced the accuracy and efficiency of IVF procedures. These advancements not only improve the success rates of fertility treatments but also streamline the workflow in IVF laboratories, attracting healthcare providers to invest in state-of-the-art microscopy solutions.

The in-vitro fertilization microscope industry is classified based on product type, end-use and region.

Based on product, the market value from the stereo microscopes segment will exhibit 8.6% growth rate between 2024 and 2032. Stereo microscopes offer enhanced depth perception and three-dimensional visualization capabilities, allowing embryologists to manipulate delicate specimens with precision during various stages of the IVF process. Additionally, the ergonomic design and user-friendly interface of these microscopes is contributing to improved workflow efficiency in IVF laboratories.

In- vitro fertilization microscope market from the academic research end-use segment is expected to witness 8.9% CAGR through 2032, backed by innovations and wider understanding of reproductive biology. Academic institutions help in conducting groundbreaking research for improving fertility treatments and advancing assisted reproductive technologies. As researchers explore new methodologies and techniques to enhance embryo development and implantation success rates, there is a growing demand for high-quality microscopy equipment tailored to the specific needs of IVF research.

Asia Pacific in-vitro fertilization microscope industry will record a 9.1% growth rate through 2032, attributed to the increasing prevalence of infertility issues. There have been significant initiatives and investments in healthcare infrastructure, particularly in countries, such as China, India, and Japan. Furthermore, the presence of a large population base and improving healthcare standards will contribute to the burgeoning demand for IVF microscopy in the region.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increased adoption due to improving success rate
  - 3.2.1.2 Rising technological advancements
  - 3.2.1.3 Rising government policies
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Restraining IVF guidelines
  - 3.2.2.2 Commoditization and industrialization
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Embryo microscopes
5.3 Stereo microscopes
5.4 Upright microscopes
5.5 Inverted microscopes

Chapter 6 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Clinics
6.3 Academic research
6.4 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 Japan
- 7.4.2 China
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 Saudi Arabia
- 7.6.2 South Africa
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa